US Stock MarketDetailed Quotes

PTPI Petros Pharmaceuticals

Watchlist

0.2700
+0.0023+0.86%

Trading Nov 27 12:26 ET

2.70MMarket Cap-71P/E (TTM)

Petros Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Petros Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q4	-- / 1.283M	--
--	2024/Q3	1.576M / 1.340M	--
--	2024/Q2	1.421M / 1.397M	--
--	2024/Q1	1.389M / 1.454M	--
--	2023/Q4	-364.250K / 1.553M	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q4-- / 1.283M--

--2024/Q31.576M / 1.340M--

--2024/Q21.421M / 1.397M--

--2024/Q11.389M / 1.454M--

--2023/Q4-364.250K / 1.553M--

Unlock Free Earnings Estimates

Open Account

Petros Pharmaceuticals Earnings Reports

Petros Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

Nov 13 17:17 ET

Petros Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

Aug 14 16:13 ET

Petros Pharmaceuticals | 10-K/A: Annual report (Amendment)

May 31 17:10 ET

Petros Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

May 15 17:06 ET

Analyst Rating

Updated: Oct 31, 2024

Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall